Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational Accepts healthy volunteers

Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)

ClinicalTrials.gov ID: NCT01730170

Public ClinicalTrials.gov record NCT01730170. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 27, 2026, 1:37 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Epilepsy is one of the most common neurological disorders affecting women of childbearing age. Poor pregnancy outcomes are increased in these women and their children. The proposed studies will increase our knowledge on multiple levels to improve care and reduce adverse outcomes in these mothers and children. An overall goal of this study is to establish the relationship between antiepileptic drug exposure and outcomes in the mother and child as well as describe and explain the variability in antiepileptic drug exposure and response.

Study identification

NCT ID
NCT01730170
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Stanford University
Other
Enrollment
565 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
14 Years to 45 Years
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2012
Primary completion
Dec 11, 2022
Completion
Dec 11, 2022
Last update posted
Jul 12, 2023

2013 – 2022

United States locations

U.S. sites
20
U.S. states
15
U.S. cities
19
Facility City State ZIP Site status
University of Alabama Birmingham Hospital- UAB Birmingham Alabama 35294-0021 —
University of Arizona - University Medical Center Tucson Arizona 85724-5023 —
Keck Hospital of the University of Southern California Los Angeles California 90089 —
Stanford University Stanford California 94305 —
University of Miami Hospital - University of Miami School of Medicine Miami Florida 33136 —
Emory University School of Medicine Atlanta Georgia 30322 —
Medical College of Georgia at Georgia Regents University Augusta Georgia 30912-0004 —
Northwestern Memorial Hospital-Northwestern University Feinberg School of Medicine Chicago Illinois 60611 —
John Hopkins Bayview Medical Center Baltimore Maryland 21224-2735 —
Brigham & Women's Hospital - Harvard Boston Massachusetts 02115-6110 —
Henry Ford Hospital Detroit Michigan 48202-2608 —
Minnesota Epilepsy Group Roseville Minnesota 55113 —
North Shore Jewish Medical Center Manhasset New York 11040-1402 —
New York University School of Medicine New York New York 10016-6402 —
Columbia University Medical Center/NY Presbyterian Hospital New York New York 10032-7133 —
Wake Forest Baptist Health-Wake Forest University School of Medicine Winston-Salem North Carolina 27157 —
University of Cincinnati UC Health University Hospital Cincinnati Ohio 45267-0525 —
Geisinger Medical Center Danville Pennsylvania 17822-9800 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 —
University of Washington Medical Center Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01730170, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 12, 2023 · Synced Sep 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01730170 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →